Search
Close this search box.
On the premiere leveraged finance transaction on the Bulgarian market in 2017, we acted for all finance parties, including the Co-Arrangers (Rabobank Antwerp, BNP PARIBAS S.A. – Sofia Branch, UniCredit Bulbank AD and ING Bank N.V. – Sofia Branch), the Agent (Citibank Europe plc, UK Branch) and the Security Agent (Citibank N.A., London Branch) in relation to a EUR 550,000,000 multi facility loan made available to Huvepharma OOD and its affiliates in Bulgaria and abroad. The team was co-lead by our Managing Partner Georgi Spasov and counsel Nadia Hadjova, supported by Nayden, Peter and Irina. This is the fourth transaction that the highly experienced team is working on with Citibank since the initial syndication of the Huvepharma loan back in 2014. Huvepharma continues to outpace all expectations for its growth and has become one of the world’s largest and fast-growing global pharmaceutical companies with a focus on developing, manufacturing and marketing human and animal health products. The borrowers – part of the Huvepharma group will use the fresh funding (including a new Capex Facility and an Acquisition Facility) to fuel its global business expansion and refinance their existing indebtedness on more favorable terms. Contact us to understand more about our vast expertise on cross border lending.

More Posts

Spasov and Bratanov successfully advised the International Finance Corporation and Raiffeisenbank International AG Austria on one of the most significant financing transactions of the year in Bulgaria: a €90 million

Read More »

On 22 November 2024 the 11th edition of CEE Competition Law Day, organized by Marta Sendrowicz – partner with A&O Shearman – Poland, took place in Sofia, Bulgaria. CEE Competition

Read More »

This year Spasov & Bratanov made its annual Christmas donation in favor of the Bulgarian Natural Sciences Olympic Teams Association thus supporting the talented Bulgarian children in their path to

Read More »

Spasov&Bratanov advised ImPulse Growth on the capital increase subject to the subscription of the shares from the increase by the warrant holders. After successfully placing the first issue of warrants

Read More »

Share: